Stock Events

Stock Events

Enveric Biosciences 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Apr 8
€0.19
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

26MarExpected
Q2 2025
Q3 2025
Next
-54.2
-39.23
-24.27
-9.3
Expected EPS
-48.354606
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-18.2MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SLZ0.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap148.9M
Corbus Pharmaceuticals works on developing and commercializing novel therapeutics to treat inflammatory and fibrotic diseases, overlapping with Enveric's target indications.
Aurora Cannabis
ACB
Mkt Cap280.01M
Aurora Cannabis is a major player in the cannabis industry, potentially competing in the medical cannabis space where Enveric operates.
Tilray Brands
TLRY
Mkt Cap1.5B
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, potentially overlapping with Enveric's market in cannabinoid-based therapeutics.
Canopy Growth
CGC
Mkt Cap418.51M
Canopy Growth Corporation operates in the cannabis and hemp business, directly competing in the broader market for cannabinoid-based products.

About

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Show more...
CEO
ISIN
US29405E5050
WKN
000A41HB6

Listings

F
DE
SLZ0.F
XNAS
US
ENVB
BOATS
BOATS
ENVB.BOATS

0 Comments

Share your thoughts

FAQ

What is Enveric Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Enveric Biosciences stocks are traded under the ticker SLZ0.F.
When is the next Enveric Biosciences earnings date?▼
Enveric Biosciences is going to release the next earnings report on March 26, 2026.
What were Enveric Biosciences earnings last quarter?▼
SLZ0.F earnings for the last quarter are -9.3 EUR per share, whereas the estimation was -54.2 EUR resulting in a +82.84% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Enveric Biosciences revenue for the last year?▼
Enveric Biosciences revenue for the last year amounts to 0 EUR.
What is Enveric Biosciences net income for the last year?▼
SLZ0.F net income for the last year is -18.2M EUR.
Does Enveric Biosciences pay dividends?▼
Yes, SLZ0.F dividends are paid en. The last dividend per share was 0.19 EUR. As of today, Dividend Yield (FWD)% is 0%.
When did Enveric Biosciences complete a stock split?▼
The last stock split for Enveric Biosciences was on October 28, 2025 with a ratio of 1:12.